Cattle in this study were born on ranches and entered the feedlots between 3 and 12 months of age. In the feedlots, we collected pooled fecal (black pin), soil (red pin), and drinking water (blue …
Sample collection details, by location, sample matrix and pen.
(A) Heatmap of the 319 ARDs (rows) identified in 87 samples (columns) collected from the beef production system. Columns are grouped by sampling location but are unclustered. ARDs are clustered …
Raw and normalized count matrix of ARDs (rows) identified by sample (columns).
Non-metric multidimensional scaling (NMDS) ordination plots of pre-slaughter sample ARD composition, depicting significant sample separation by (A) matrix (Stress=0.13, R=0.41, p=0.001), and …
Stress values for ARD ordination at arrival and exit were 0.08 and 0.03, respectively, and for microbiome species ordination at arrival and exit were 0.06 and 0.07, respectively. Soil (red), water …
Proportion of arrival (n=8 soil, 8 fecal, 8 water) and exit (n=8 soil, 8 fecal, 8 water) samples that contained at least one ARD in each resistance mechanism (n=33), grouped by resistance class.
In each NMDS plot, a polygon corresponds to one unit (i.e., pen, feedlot or state) and represents the convex hull for that unit (i.e. the smallest amount of space within the graph that contains all …
NMDS ordination, adonis, and anosim results at the ARD, mechanism and class levels, by pen, feedlot, and state variables.
(A) Boxplot of Shannon’s diversity at the species level, pre- vs. post-slaughter across all sample matrices. Shannon’s diversity was significantly lower in post-slaughter samples when tested using …
Shannon’s diversity, taxa table and model output for Figure 7.
Sheet 1 ('Figure 7A') includes sample metadata and Shannon's Diversity Index calculated at the species level. Sheet 2 ('Figure 7B taxa table') includes the taxa count matrix, by sample, that was used to model log2-fold changes in abundance for Figure 7B and Figure 7—figure supplement 1. Sheet 3 ('Figure 7B model output') shows model output for log2-fold change in abundance at the genus level across all pre- and post-slaughter samples. Sheet 4 ('Figure 7 supp. Model output') shows model output for log2-fold change in abundance at the genus level between pre- and post-slaughter swab samples.
Log2-fold change in abundance of genera from pre- to post-slaughter versus adjusted P–value, using only swab samples. Dot size is proportional to the average abundance of the genus across all …
Antimicrobial drug usage in the study population.
Drug (dosage) | Drug Class | Primary Reason for Use | Number of Animals treated (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Pen A | Pen B | Pen C | Pen D | Pen E | Pen F | Pen G | Pen H | |||
Tylosin phosphate (11 mg/kg diet dry matter)a | Macrolide | Liver abscess prevention | 244 (100) | 281 (100) | 152 (100) | 189 (100) | 230 (100) | 230 (100) | 265 (100) | 150 () |
Tulathromycinb (2.5 mg/kg BWc) | Macrolide | BRDd Treatment | 15 (6.1) | 16 (5.7) | 12 (7.9) | 3 (1.6) | 19 (8.3) | 3 (1.3) | 8 (3.0) | 5 (3.3) |
Oxytetracyclinee (20 mg/kg BW) | Tetracycline | BRD Treatment | 1 (0.4) | 1 (0.4) | 43 (28.3) | 9 (4.8) | 6 (2.6) | 2 (0.9) | 13 (4.9) | 10 (6.7) |
Oxytetracycline and Flunixin meglumineb (30 mg/kg BW and 2 mg/kg BW) | Tetracycline | BRD Treatment | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Danofloxacin mesylateb (8 mg/kg BW) | Fluoroquinolone | BRD Treatment | 0 (0.0) | 4 (1.4) | 1 (0.7) | 0 (0.0) | 4 (1.7) | 7 (3.0) | 2 (0.8) | 0 (0.0) |
Enrofloxacinb (7.7 mg/kg BW) | Fluoroquinolone | BRD Treatment | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.8) | 0 (0.0) |
Ceftiofur sodiume (1 mg/kg BW) | β-lactam | BRD Treatment | 0 (0.0) | 0 (0.0) | 2 (1.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Ceftiofur crystalline free acidb (6.6 mg/kg BW) | β-lactam | BRD Treatment | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 4 (1.5) | 1 (0.7) |
aThis AMD was in all rations of all cattle for the duration of the feeding period
bEach treated animal received a dose that persisted in target tissues at effective therapeutic concentrations for 3 days, according to the drug label.
cBW = body weight
dBRD = bovine respiratory disease
eEach treated animal received a dose that persisted in target tissues at effective therapeutic concentrations for 1 day, according to the drug label.
ARDs to critically important antimicrobials that were specifically searched for in all 87 samples.
Classification | Group | ARD ID (database) | Sample Type, Location | Alignment characteristics |
---|---|---|---|---|
Carbapenemases | bla(OXA) | Bla)OXA-347:JN086160 (ARG-ANNOT)a (Bla)OXA-235:JQ820240 (ARG-ANNOT) | 1 x water, holding 1 x soil, arrival 1 x soil, arrival | 100% nucleotide homology with reference across ≥ 80% of gene (≥ 1x coverage) 100% nucleotide homology to KSG, FGN and STFK motifs |
bla(SME) | Not identified | Not identified | Not identified | |
bla(IMI) | Not identified | Not identified | Not identified | |
bla(NDM) | Not identified | Not identified | Not identified | |
bla(GES) | Not identified | Not identified | Not identified | |
bla(KPC) | Not identified | Not identified | Not identified | |
bla(cphA)b | cphA1_2_AYAY261377 (Resfinder) | 3 x water, holding | 100% amino acid homology to reference (4 silent substitutions) | |
Extended-spectrum β-lactamase | bla(TEM) | (Bla)TEM-116:AY425988 (ARG-ANNOT) | 1 x water, holding | 100% nucleotide homology with reference across ≥ 80% of gene (≥ 1x coverage) |
bla(SHV) | Not identified | Not identified | Not identified | |
bla(CTX-M) | Not identified | Not identified | Not identified | |
bla(CMY) | Not identified | Not identified | Not identified | |
Quinupristin-dalfopristin resistance | vga/vat | GQ205627.2.gene3 (CARD) AND (MLS)VgaD:GQ205627:1394-2971:1578 | 1 x soil, arrival | 100% nucleotide homology to Walker A and B motifs; silent substitution in RSGG motif 100% nucleotide homology to LβH hexapeptide repeat domain |
Multi-drug resistance to PhLOPSA c | cfr | (MLS)CfrA:AM408573 (ARG-ANNOT) | 4 x swab, truck (all in Texas) | 100% nucleotide homology with reference across ≥ 95% of gene (≥ 1x coverage) |
aNote that phenotypic resistance to carbapenems has not been confirmed for this ARD
bbla(cphA) is a strict carbapenemase
cConfers multi-drug resistance to phenicol, lincosamide, oxazolidinones (linezolid), pleuromutilins, and streptogramin A
Sequencing, filtering and host removal statistics for all samples.
List of 319 ARDs identified across all 87 samples.
Resistance classification by class and mechanism